2024-10-16 - Analysis Report
## HCA Healthcare Inc. (HCA) Stock Analysis Report

**Company Overview:** HCA Healthcare Inc. is a leading provider of healthcare services in the United States.

**Performance Analysis:**

**1. Performance vs. S&P 500:**

* **Cumulative Return (HCA):** 321.93
* **Cumulative Return (VOO):** 135.82
* **Performance Gap:** 186.11 (Relative Divergence: 92.48%)

HCA has significantly outperformed the S&P 500, with a cumulative return more than twice that of the index.  The current relative divergence indicates that HCA's performance has been strong historically, exceeding the S&P 500 by a wide margin. 

**2. Recent Price Movement:**

* **Closing Price:** 394.54
* **5-day Moving Average:** 385.6
* **20-day Moving Average:** 397.96
* **60-day Moving Average:** 380.05

The stock price is currently above its 5-day and 60-day moving averages, suggesting a positive short-term trend. However, it is slightly below its 20-day moving average, indicating potential short-term consolidation.

**3. Technical Indicators:**

* **RSI:** 40.08
* **PPO:** -0.66
* **Delta_Previous_Relative_Divergence:** -3.83 
* **Expected Return:** 7.69664229333333% (5-year expected return, exceeding S&P 500)

The RSI value suggests that the stock is currently in neutral territory, neither overbought nor oversold. The PPO indicator is negative, indicating that the stock's momentum is slowing. The recent relative divergence indicates a slight short-term decline, but the positive expected return suggests potential future growth.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-29 | 5.6 | 17.49 B$ |
| 2024-05-02 | 6.01 | 17.34 B$ |
| 2023-10-26 | 3.98 | 16.21 B$ |
| 2023-08-02 | 4.35 | 15.86 B$ |
| 2024-07-29 | 4.35 | 15.86 B$ |

HCA has consistently demonstrated strong revenue and earnings growth over the past few quarters.  The most recent earnings report (2024-07-29) showed a slight decline in revenue but a strong increase in EPS compared to the previous quarter.  The company's strong performance is driven by factors such as increasing patient volume, rising healthcare spending, and its diversified geographic presence.

**5. News and Recent Issues:**

* **Recent Market Outlook:** HCA has received a positive outlook from analysts based on strong earnings and revenue growth. The company's focus on cost management and investment in technology are considered key drivers for future success.
* **Analyst Opinions:**  Analysts are generally positive about HCA's future prospects. Finbold reports a consensus rating of "buy" with a target price of $410, indicating potential upside.
* **Performance Highlights:** HCA has consistently outperformed the S&P 500 over the past year.  Its strong financial performance, coupled with the growing demand for healthcare services, makes it an attractive investment opportunity.

**6. Conclusion:**

HCA Healthcare Inc. presents a compelling investment case with its strong performance history, positive market outlook, and favorable technical indicators.  The company's focus on delivering high-quality healthcare services, along with its efficient operations and expansion strategy, has positioned it for continued growth and profitability. However, it's important to consider potential risks such as regulatory changes and competition within the healthcare industry. Investors should carefully evaluate their risk tolerance and investment goals before making any decisions.

**7. Recommendations:**

* **Long-Term Investors:**  HCA presents a compelling long-term investment opportunity due to its strong performance and positive industry outlook.
* **Short-Term Traders:** While the stock's recent price movement suggests potential for further gains, it is important to monitor technical indicators and market trends closely for potential short-term reversals.
* **Overall:** HCA remains a strong stock pick for investors seeking exposure to the healthcare sector. Its consistent growth and profitability make it a desirable asset for both long-term and short-term investors.
